Diabetes, Obesity and Metabolism
© John Wiley & Sons Ltd
Edited By: R. Donnelly and A. Garber
Impact Factor: 6.198
ISI Journal Citation Reports © Ranking: 2015: 13/131 (Endocrinology & Metabolism)
Online ISSN: 1463-1326
Authors are reminded that Diabetes,Obesity and Metabolism is primarily a journal of pharmacology and therapeutics.
The scope of the journal includes human pharmacokinetics and pharmacodynamics, cost-effectiveness studies, preclinical pharmacology, and phase I-IV clinical trials. High-quality meta-analyses and systematic reviews that provide original information on treatment effects and safety are also considered as original research papers.
The journal welcomes submission of (1) Original Research Papers, (2) Brief Reports, (3) Letters to the Editor (Correspondence), usually commenting on a recent publication in the journal, and (4) Review Articles with an emphasis on therapeutics, although most Reviews are commissioned by the Reviews Editor.
Please submit your manuscript online at http://mc.manuscriptcentral.com/dom. Submissions can be uploaded as Rich Text Format (RTF) files plus separate figure files (GIF, JPEG, BMP, TIFF, PICT) or a single Portable Document Format (PDF) file including artwork. For more information on preparing the manuscripts for online submission, please read the detailed instructions at http://mc.manuscriptcentral.com/dom. Additional help is available by emailing email@example.com. At the time of submission, authors are asked to make a declaration of any competing interests and to state their individual contributions to the work.
Contact details for The Editorial Office:
Editorial Office (Diabetes, Obesity and Metabolism)
University of Nottingham School of Medicine
The Medical School
Royal Derby Hospital, Uttoxeter Road
Derby, DE22 3DT, UK
Tel: +44 (0) 1332 724684
E-mail enquiries: firstname.lastname@example.org
Format of Manuscripts
(i) Original Research Papers
Original papers should be structured as follows:
Title page: Author names, affiliations, and a short running title. The word counts for the abstract and the main body of the text (excluding references and legends) should be clearly stated, along with the number of references, tables and figures. Please conform to the guidance on manuscript size below
Structured abstract: Subheadings - aims, materials and methods, results, and conclusions (maximum 250 words);
Main manuscript: Should be typed double-spaced and structured as follows: introduction; materials and methods (including appropriate subsections, e.g. statistical methods); results; discussion; acknowledgements; references (normally 40); legends to figures; tables; and figures.
Original manuscripts should be 3,500 words (not including references, tables and figures). Manuscripts should include a maximum of 5 Figures and/or tables. Additional tables or figures and/or extra methodological detail can be included in a separate Supplementary Appendix. The production and handling Editors may relocate tables or figures into a Supplementary Appendix prior to the production of page proofs if the manuscript exceeds these specifications at the time of final acceptance.
(ii) Brief Reports
These are short communications of original research which are fully cited references. They provide a concise report of a research analysis with a clear conclusion. Manuscripts should include a short non-structured abstract (180 words maximum) and be sub-divided into sections (Introduction, Methods, Results and conclusions). The total manuscript length should not exceed 1800 words, excluding references and abstract. Brief Reports can include a maximum of 15 references (+ any number of references to work published in Diab. Obes. Metab..) and 2 figures OR tables. Additional information (e.g Tables or Figures) can be provided as a Supplementary Appendix.
(iii) Review Articles
We welcome unsolicited narrative reviews on important topics of therapeutics and pharmacology. Good review articles should provide novel insights, analysis and interpretation of the published literature and offer a balanced critical appraisal of established or emerging therapies. Formal Systematic reviews and meta-analyses should be formatted and submitted as original research papers. Review articles should not exceed 5000 words and 100 references. Additional data (eg Tables) can be provided as a Supplementary Appendix. The handling Editor may relocate tables or figures into a supplementary Appendix if the manuscript exceeds these specifications and/or 10 printed pages.
(iv) Letters to the Editor
Correspondence relating to work that has been published in the journal, and/or other brief comments, case reports or observations, may be submitted as a succinct letter to the editor.
Fast-Track Assessment and Publication of Clinical Trials
The journal offers a fast track peer-review and publication service for original research papers that communicate the results of multicentre, randomised clinical trials of new or existing therapeutic agents. Such studies must be of sufficient originality, importance and general interest to warrant fast track peer review and (if accepted) immediate publication in the next issue of the journal.
Authors considering submission through this route should send a request and the structured abstract to the Editorial Office by email, prior to uploading the full manuscript onto Manuscipt central. The Editors will advise whether fast track consideration is appropriate; decisions are usually made within 72 hours. For manuscripts processed by the fast-track route, the Editors strive to obtain a thorough peer review and make the first decision to authors within 28 days of submission. A processing fee of USD 2,000 (plus VAT in the UK) is charged for this service. If the manuscript is accepted (e.g after revision and resubmission), it will be published in the next available issue of the journal.
Enquiries about fast track submission should be sent to email@example.com.
The ethical aspects of all studies will be noted particularly when assessing manuscripts. For human studies, only those studies conducted in accordance with ICH-GCP practice should be submitted for publication. Details should be given of the approval of the study protocol by an appropriate Human or Animal Research Ethics committee. The human or animal ethics committee which approved the protocol should be described in sufficient detail to allow the committee to be identified.
All measurements should be expressed as SI units. If, however, other units are used, a conversion factor should be included in the Methods section.
Statistical methods should be described clearly in the methods section with references when appropriate. Editors and referees will be concerned particularly that any study described had sufficient statistical power for its purpose, and where appropriate, considerations of the power of the study should be laid out in the methods section. In the results section, 95% confidence intervals should be cited whenever possible for all important endpoints for the study.
Copyright Transfer Agreement
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services where, via the Wiley Author Licensing Service (WALS), they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs.
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial - NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license: Creative Commons Attribution License OAA. To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
Figures should not exceed A4 and may be in the form of original drawings, recorded tracings or high quality photographic prints made from them. It is the policy of the journal to reproduce all color artwork without charge to the authors.
Video Abstracts: A video abstract can be a quick way to make the message of your research accessible to a much larger audience. Wiley and its partner Research Square offer a service of professionally produced video abstracts, available to authors of articles accepted in this journal. You can learn more about it, and purchase one for your article, at http://www.wileyauthors.com/videoabstracts . If you have any questions, please direct them to firstname.lastname@example.org .
References should be cited using the AMA style (see examples below).
The references in the manuscript text should be numbered consecutively in the order in which they appear and indicated by Arabic numerals as superscripts. The reference list, presented in numerical order, should include the names of all authors (if there are more than six authors, only the first three should be given followed by et al.), the full title of the article, title of publication (abbreviated in accordance with Index Medicus), the year, volume number and first and last page numbers. References to books should, in addition, include the names of the editor, the edition number, where appropriate, and the town of origin and name of publisher. The accuracy of the reference is the responsibility of the author. Examples are given below.
Bigby ME. The end of the sunscreen and melanoma controversy: a quantitative review. Ann Intern Med. 2003;139(12):966-978.
Klein R, Hein BEK, Moss SE, et al. The relation of retinal vessel ralilxtr to the incidence and progression of diabetic retinopathy, XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophtbalmol 2004;122(1):76-83.
Smeeth L, Iliffe S. The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis. Nature. 2004;427(6974):510-517. doi:10.1038/nature02312.
Modlin J, Jenkins P. Decision Analysis in Planning for a Polio Outbreak in the United States. San Francisco, CA: Pediatric Academic Societies; 2004.
Adkinson N, Yunginger J, Busse W, Bochner B, Holgate S, Middleton E, eds. Middleton's Allergy: Principles and Practice. 6th ed. St. Louis, MO: Mosby; 2003.
Solensky R. Drug allergy: desensitization and treatment of reactions to antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen Immunotherapy. 3rd ed. New York, NY: Marcel Dekker; 2004:585-606.
World Health Organization. Injury: A Leading Cause of the Global Burden of Disease, 2000. Geneva, Switzerland: World Health Organization/Plenum; 2002.
International Society for Infectious Diseases. ProMED-mail Web site. hnp://www.promedmail.org. Accessed April 29, 2004.
Epi Info [computer program]. Version 3.2. Atlanta, GA: Centers for Disease Control and Prevention; 2004.
All support, financial or otherwise, for any work described should be acknowledged, with the exception of support from employing institutions identifiable from the title page.
The contribution of each author should be stated at the time of submission. This information will be published at the end of the paper.
Please provide if deemed necessary.
Conflict of interests
Information provided at the time of submission with be published, or ‘no potential conflict of interests’ will appear.
The corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. The software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html.
This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Hard copy proofs will be posted if no e-mail address is available. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charged separately.
All manuscripts are subject to editing for length, clarity and conformity with Diabetes, Obesity and Metabolism style. Word count limitations should be observed. Tables and figures will be published as supporting information if the proofs of the manuscript exceed 10 print pages.
Diabetes, Obesity and Metabolism now offers Accepted Articles for all manuscripts. This service ensures that accepted 'in press' manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles appear in PDF-only format, without the accompanying full-text HTML. Each manuscript is assigned a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
Diabetes, Obesity and Metabolism also offers Early View for all manuscripts. This service ensures that all accepted and proofed manuscripts are published online very soon after proofing but before inclusion in a full issue.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their articles. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see here.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at https://wileyonlinelibrary.com/onlineopen.
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.
Online production tracking is now available for your article through Wiley-Blackwell's Author Services
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e- mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Author material archive policy
Please note that, unless specifically requested, Wiley-Blackwell will dispose of all hardcopy or electronic material submitted 2 months after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible if you have not yet done so.